Long-term results of a multidisciplinary medication optimization program for older adults including primary care and hospital team.

Background: Therapeutic optimization and deprescribing in older adults face multiple barriers, whereas drug-related hospitalization increased from 3.6% to 8.5% between 2006 and 2018. The OPTIMEDOC program aims to optimize older adults' prescriptions through clinical medication review conducted by a...

Descripción completa

Detalles Bibliográficos
Publicado en:European Journal of Clinical Pharmacology Vol. 81; no. 10; pp. 1461 - 1472
Autores principales: Guerin, Camille, Leguillon, Romain, Cherel, Albane, Valembois, Lucie, Brochard, Gwladys, Pierre, Mélissa, Bourderont, Antoine, Gaillot, Bérénice, Bernardeau, Claire, Vaesken, Céline, Tebourski, Ines, Descatoire, Pablo, Saint-Lorant, Guillaume, Villain, Cédric, Meurant, Alexandre
Formato: research tables/charts Journal Article
Publicado: Springer Nature Oct2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=188021172&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 188021172
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00316970
        NP9
      jtl: European Journal of Clinical Pharmacology
      issn: 00316970
      maglogo: N
    pubinfo:
      dt: Oct2025
      vid: 81
      iid: 10
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        188021172
        186948803
        188021172
        188021172
        10.1007/s00228-025-03889-5
        188021172
      ppf: 1461
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Long-term results of a multidisciplinary medication optimization program for older adults including primary care and hospital team.
      aug:
        au:
          Guerin, Camille
          Leguillon, Romain
          Cherel, Albane
          Valembois, Lucie
          Brochard, Gwladys
          Pierre, Mélissa
          Bourderont, Antoine
          Gaillot, Bérénice
          Bernardeau, Claire
          Vaesken, Céline
          Tebourski, Ines
          Descatoire, Pablo
          Saint-Lorant, Guillaume
          Villain, Cédric
          Meurant, Alexandre
        affil: https://ror.org/027arzy69 Department of Pharmacy, University Hospital of Caen Normandie, 14000, Caen, France
      sug:
        subj:
          Multidisciplinary Care Team
          Primary Health Care
          Deprescribing In Old Age
          Program Implementation
          Medication Review
          Physicians, Family
          Human
          Male
          Female
          Aged
          Aged, 80 and Over
          Nonexperimental Studies
          Retrospective Design
          Collaboration
          Data Analysis Software
          Descriptive Statistics
          Mann-Whitney U Test
          Chi Square Test
          Academic Medical Centers France
          France
          Pharmacists
          Geriatricians
          Patients
          Caregivers
          Adverse Drug Event Risk Factors
          Prospective Studies
          Geriatric Assessment
          Aged: 65+ years
          Aged, 80 & over
          Male
          Female
      ab: Background: Therapeutic optimization and deprescribing in older adults face multiple barriers, whereas drug-related hospitalization increased from 3.6% to 8.5% between 2006 and 2018. The OPTIMEDOC program aims to optimize older adults' prescriptions through clinical medication review conducted by a multidisciplinary team including clinical pharmacist, geriatrician, and general practitioner (GP). This collaboration between primary care and hospital team aims to enable appropriate and sustainable prescriptions. Purpose: This study aimed to assess the implementation of therapeutic optimizations at least 6 months after the intervention. The secondary objective was to document the most frequently deprescribed and newly introduced medications and their long-term implementation rate. Methods: This observational study was conducted in a university hospital, including patients who benefited from the OPTIMEDOC program from April 2022 to April 2024. The primary outcome was the long-term implementation rate of recommendations. The secondary outcome was a description of the optimized drugs according to ATC2 classes. Results: Among 1580 validated therapeutic recommendations for 143 patients included with an average age of 86.4 years old, 1473 were followed up (93.2%). Of these, 1017 were successfully implemented over 1 year (69.0%). Specifically, 81.8% of deprescriptions, 58.3% of introductions, and 70.5% of modifications were implemented. Although vaccine introductions were the most frequently recommended (n = 222), only 41% were implemented. Regarding deprescribing, psycholeptics, psychoanaleptics, and drugs for acid-related disorders had a long-term implementation rate of over 75%. Conclusion: These results validate the OPTIMEDOC program as an effective strategy for sustainable therapeutic optimization, especially for deprescribing. Engaging community pharmacists could further enhance the implementation of therapeutic recommendations.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N